Bendamustine in patients with relapsed or refractory multiple myeloma

Por Michael, M, Bruns, I, Bölke, E, Zohren, F, Czibere, A, Safaian, N N, Neumann, F, Haas, R, Kobbe, G, Fenk, R
Publicado em 2010

Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia

Por Schlenk, R F, Frech, P, Weber, D, Brossart, P, Horst, H-A, Kraemer, D, Held, G, Ringhoffer, M, Burchardt, A, Kobbe, G, Götze, K, Nachbaur, D, Fischer, T, Lübbert, M, Salih, H R, Salwender, H, Wulf, G, Koller, E, Wattad, M, Fiedler, W, Kremers, S, Kirchen, H, Hertenstein, B, Paschka, P, Gaidzik, V I, Teleanu, V, Heuser, M, Thol, F, Döhner, K, Krauter, J, Ganser, A, Döhner, H
Publicado no Leukemia (2017)